News
![idorsia-building-04--highres](https://pharmaphorum.com/wp-content/uploads/2020/01/idorsia-building-04-highres.jpg)
Idorsia is first to EU market with orexin insomnia drug
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and